Many experimental studies in cultured cells and animal models of T1DM have provided convincing evidence that miRNAs can participate in controlling β-cell fate, autoimmune damage of β-cells, and regulation of insulin synthesis and secretion [60]. This evidence concerns the gene INS and type 1 diabetes mellitus.